Cleared Traditional

Ensizor Monopolar Endoscopic Scissors (K180134) - FDA 510(k) Clearance

Class II Gastroenterology & Urology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 2018
Decision
163d
Days
Class 2
Risk

K180134 is an FDA 510(k) clearance for the Ensizor Monopolar Endoscopic Scissors. Classified as Forceps, Biopsy, Electric (product code KGE), Class II - Special Controls.

Submitted by Slater Endoscopy, LLC (Miami Lakes, US). The FDA issued a Cleared decision on June 29, 2018 after a review of 163 days - an extended review cycle.

This device falls under the Gastroenterology & Urology FDA review panel, regulated under 21 CFR 876.4300 - the FDA gastroenterology and urology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Gastroenterology & Urology review framework, consistent with the majority of Class II 510(k) submissions.

View all Slater Endoscopy, LLC devices

Submission Details

510(k) Number K180134 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 17, 2018
Decision Date June 29, 2018
Days to Decision 163 days
Submission Type Traditional
Review Panel Gastroenterology & Urology (GU)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
33d slower than avg
Panel avg: 130d · This submission: 163d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code KGE Forceps, Biopsy, Electric
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 876.4300
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Gastroenterology & Urology devices follow this clearance model.

Regulatory Consultant

C2c Development, LLC
Craig Pagan

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - KGE Forceps, Biopsy, Electric

All 19
Devices cleared under the same product code (KGE) and FDA review panel - the closest regulatory comparables to K180134.
Ensure Single-Use Coagulation Forceps
K202438 · Micro-Tech (Nanjing) Co., Ltd. · Mar 2021
Avulsion Forceps
K183428 · STERIS Corporation · Apr 2019
Disposable Hot Biopsy Forceps
K180018 · Micro-Tech (Nanjing) Co., Ltd. · Jul 2018
Captura® Disposable Hot Biopsy Forceps
K171973 · Wilson-Cook Medical, Inc. · Mar 2018
Single Use Hot Biopsy Forceps FD-231
K171916 · Olympus Medical Systems Corp. · Oct 2017
RADIAL 4 HOT BIOPSY FORCEPS BOX 5
K101657 · Boston Scientific Corp · Oct 2010